Master’s Programme Pharmaceutical Sciences – Drug Development and Regulatory Affairs

The aim of this joint English-language Master's programme is to train experts who understand the processes required for the development of new medicinal products in their entirety and are able to apply and successfully implement them in their future professional environment.

Graduates receive a technically and scientifically sound education in the field of drug development and the regulations required for this. This includes relevant knowledge of molecular disease processes that can be influenced by drugs and the molecular structures that can serve as targets for therapeutics.

Graduates have detailed knowledge of the strategies and methods required for the preclinical and clinical development and testing of medicinal products and the theoretical and practical regulatory knowledge required for successful marketing authorisation in Europe. They are therefore able to independently and successfully plan, organise and carry out complex projects in the context of modern drug development and accompany them through to final market approval. They have the opportunity to specialise further in the field of medicinal products within the framework of application-oriented projects.

In particular, graduates will have special skills in the following subject areas:

• Preclinical drug development
• Quality aspects of medicinal products
• Clinical testing and development of medicinal products
• Good manufacturing practice, good clinical practice, good laboratory practice
• Biostatistics and data management
• Drug regulation and marketing authorisation
• Pharmacoeconomics, drug monitoring
• Gender and diversity in the development and use of medicinal products

No, this master’s programme does not focus on drug discovery. Instead, it emphasizes the qualitative processes and regulatory frameworks involved in non-clinical and clinical aspects of drug authorization. You will learn about these topics from leading experts with extensive experience in the field. Students gain in-depth knowledge of the drug development process and valuable insights into regulatory practices, with perspectives from both pharmaceutical companies and regulatory boards.

No, it is not a clinical pharmacy/pharmacology programme. Clinical pharmacy is part of our Master’s Programme in Pharmacy.

Yes, it is generally possible to pursue this programme alongside another master’s programme. However, keep in mind that this may extend the duration of your studies. While some lectures will also be available online, attendance of many practical and seminars require attendance.

The admission process for this master’s programme is organized and conducted by the Medical University of Innsbruck for all applicants.

However, the admission itself takes place at the Leopold-Franzens-University Innsbruck.

Please note: While a completed bachelor’s degree is not required during the initial application and admission procedure, you must have successfully obtained your bachelor’s degree by the end of the admission period to finalize your enrollment.

Learn more about the admission process here:
https://www.i-med.ac.at/studium/zulassung/zulassung_pharm_sci.html.en

The Master’s programme qualifies students for subsequent employment with pharmaceutical companies, regulatory authorities, clinical research organisations and for further studies in national and international doctoral programs.

Graduates tracking: Shows which occupational fields students enter after graduation

More offers

Con­tin­u­ing edu­ca­tion

Career Ser­vice